Newest Advances in Stem Cell Transplantation Offer Promise for Complex Hematologic Malignancies
Dana-Farber Study Finds Up-front Chemotherapy Boost Could Benefit Patients with Non-Small Cell Lung Cancer
Potent Oral Agent Acting as Immunotherapy and Targeted Treatment Produces High Response Rate in Certain Patients
Studies Reveal How Tobacco Industry May Try to Get Around Proposed FDA Ban on Menthol Flavor
Roswell Park Immunologists Identify Targetable Strategy for Reducing Solid-Tumor Cancer Metastasis
Roswell Park Clinical Trials Add Beta Blocker to Arsenal Against Esophageal Cancer
Clinical Trials Offer New Approaches to CAR T-Cell Therapy and Oral, Time-Limited Treatment for Patients with CLL or Lymphoma
Biotech Executive Returns to Roswell Park to Lead Expansion of Cell Therapy Production and Grow Industry Partnerships
Final Overall Study Analysis Continues to Show Benefit of Sacituzumab Govitecan in Advanced HR+ Breast Cancer
Allogenic Hematopoietic Cell Transplant a Viable Option for all Patients with High-Risk MDS
Cell Therapy That Repairs Cornea Damage with Patient’s Own Stem Cells Achieves Positive Phase I Trial Results
Study Shows Immunotherapy May Benefit a Subset of Patients with Penile Cancer
Study Uncovers Epigenetic Source of Resistance to Targeted Therapy in EGFR-mutant Lung Cancer
AI-Driven Muscle Mass Assessment Could Improve Care for Head and Neck Cancer Patients
Dana-Farber AI-Model Predicts Primary Source of Cancer Using Gene Sequencing Data
Showing 91 - 105 of 962 results
Previous| 1... 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 ...65 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
